Search Results 181-190 of 15965 for pharmacogenetics
Pegfilgrastim-jmdb injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...
About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...
This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...
Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily recognized as ...
The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.
Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potential germline mutations may increase ...
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
About this study. The purpose of this research is to develop a better understanding of the cause of vascular overgrowth syndromes and to develop a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.